Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2025-03-21 Remuneration Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
8.1. Remuneration_Policy_2025_EN.pdf
Remuneration Information Classification · 1% confidence The document is explicitly titled "UCB Remuneration Policy 2025" and details the philosophy, policies, and proposed changes regarding the compensation for the Executive Committee and Non-Executive Directors. This content directly relates to executive and director compensation, which aligns perfectly with the definition of Remuneration Information (DEF 14A). Although the document mentions it is subject to approval by the General Meeting of Shareholders, the document itself is the policy document detailing remuneration, not the voting results (DVA) or the proxy solicitation materials (PSI). It is a detailed policy document, not a short announcement (RPA/RNS).
2025-03-21 English
3.2 UCB SA_Management Report Statutory Accounts 2024 FR Final.pdf
Management Reports Classification · 1% confidence The document is explicitly titled "Rapport annuel du Conseil d'Administration pour l'exercice social se clôturant le 31 décembre 2024" (Annual Report of the Board of Directors for the fiscal year ending December 31, 2024). It discusses the financial results for the year 2024, balance sheet details, proposed dividend allocation, and requests discharge for the administrators for the fiscal year ending December 31, 2024. This content strongly aligns with the comprehensive annual reporting requirements. Although it frequently refers to the 'Rapport Annuel Intégré 2024 du Groupe UCB' for consolidated details, this specific document is the statutory annual report of the parent company (UCB SA) presented to shareholders for approval, which is the core function of a 10-K equivalent filing in this context, even if the specific jurisdiction uses a different nomenclature for the statutory filing. Given the comprehensive nature covering the full fiscal year and statutory approvals, '10-K' (Annual Report) is the most appropriate classification among the provided options, distinguishing it from a mere Earnings Release (ER) or Interim Report (IR).
2025-03-21 French
9.3. Explanatory Note on Remuneration_NL.pdf
Remuneration Information Classification · 1% confidence The document text is titled "Toelichting op voorgestelde wijzigingen in het remuneratiebeleid van UCB" (Explanation of proposed changes to UCB's remuneration policy). It extensively details proposed changes to the compensation (remuneration) for Non-Executive Directors (NEDs) and the Executive Committee, including tables comparing current and proposed annual fees, committee fees, and introducing new shareholding guidelines. The content directly addresses executive and director compensation structure and levels, which is the core subject matter of a Remuneration Report or Proxy Statement related to compensation. Given the detailed nature of compensation proposals and justifications, this aligns most closely with the information typically found in a Proxy Statement (DEF 14A in US context, or similar governance/remuneration disclosure). Since the document focuses specifically on remuneration policy changes and is not a general annual report (10-K) or a simple announcement of a vote result, the most specific classification is Remuneration Information (DEF 14A).
2025-03-21 Dutch
9.1 Explanatory Note on Remuneration_EN.pdf
Remuneration Information Classification · 1% confidence The document is titled "Explanatory Note on proposed changes to the UCB Remuneration Policy" and details proposed amendments to the compensation structure for Non-Executive Directors (NEDs) and the Executive Committee. It explicitly discusses remuneration levels, peer group comparisons, and proposed changes to retain global talent. This content directly relates to the compensation and remuneration practices of the company's leadership, which aligns precisely with the definition of Remuneration Information (DEF 14A), which covers compensation for top executives and directors.
2025-03-21 English
4.2 UCB_SA_Statutory Auditor Report 2024 FR.pdf
Audit Report / Information Classification · 1% confidence The document is explicitly titled "Rapport du commissaire" (Auditor's Report) and addresses the "assemblée générale" (General Meeting) regarding the fiscal year ending 31.12.2024. It contains the auditor's opinion ("Opinion sans réserve") on the annual accounts, discusses key audit matters, and covers other legal and regulatory obligations related to the annual report. This content perfectly matches the definition of an Audit Report/Information (AR), which covers standalone audit reports, even though it relates to the annual accounts. Since the document *is* the audit report itself, and not just an announcement of its publication, AR is the most precise classification, rather than RPA or 10-K (which is the full annual report, whereas this is the specific auditor's opinion section thereof). FY 2024
2025-03-21 French
8.3. Remuneration_Policy_2025_NL.pdf
Remuneration Information Classification · 1% confidence The document is titled "UCB Remuneratiebeleid 2025" (UCB Remuneration Policy 2025) and explicitly describes the compensation philosophy, policies, and practices for the Executive Committee and Non-Executive Directors, referencing Belgian corporate law (WVV) and the Corporate Governance Code. This content directly relates to the compensation and remuneration of management and directors. The available classification codes include 'DEF 14A' (Remuneration Information) and 'CGR' (Governance Information). Since the primary focus is the detailed remuneration policy, 'DEF 14A' is the most specific fit, as DEF 14A filings in the US context often cover executive compensation details, which aligns with the content here, even though the document is Belgian. It is a policy document, not a short announcement, so RPA/RNS is less likely. It is more specific than general Governance Information (CGR).
2025-03-21 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.